首页> 美国卫生研究院文献>Nucleic Acids Research >s-RT-MELT for rapid mutation scanning using enzymatic selection and real time DNA-melting: new potential for multiplex genetic analysis
【2h】

s-RT-MELT for rapid mutation scanning using enzymatic selection and real time DNA-melting: new potential for multiplex genetic analysis

机译:s-RT-MELT通过酶促选择和实时DNA融合进行快速突变扫描:多重遗传分析的新潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The rapidly growing understanding of human genetic pathways, including those that mediate cancer biology and drug response, leads to an increasing need for extensive and reliable mutation screening on a population or on a single patient basis. Here we describe s-RT-MELT, a novel technology that enables highly expanded enzymatic mutation scanning in human samples for germline or low-level somatic mutations, or for SNP discovery. GC-clamp-containing PCR products from interrogated and wild-type samples are hybridized to generate mismatches at the positions of mutations over one or multiple sequences in-parallel. Mismatches are converted to double-strand breaks using a DNA endonuclease (Surveyor™) and oligonucleotide tails are enzymatically attached at the position of mutations. A novel application of PCR enables selective amplification of mutation-containing DNA fragments. Subsequently, melting curve analysis, on conventional or nano-technology real-time PCR platforms, detects the samples that contain mutations in a high-throughput and closed-tube manner. We apply s-RT-MELT in the screening of p53 and EGFR mutations in cell lines and clinical samples and demonstrate its advantages for rapid, multiplexed mutation scanning in cancer and for genetic variation screening in biology and medicine.
机译:对人类遗传途径(包括介导癌症生物学和药物反应的途径)的迅速增长的了解,导致对在人群或单个患者基础上进行广泛而可靠的突变筛查的需求日益增长。在这里,我们描述s-RT-MELT,这是一种新颖的技术,可以对人类样品中的种系或低水平体细胞突变或SNP发现进行高度扩展的酶促突变扫描。将来自被询问的样品和野生型样品的含GC-clamp的PCR产物杂交,以在一个或多个平行的序列上的突变位置产生错配。使用DNA内切核酸酶(Surveyor™)将错配转换为双链断裂,并将寡核苷酸尾部酶促地连接在突变位置。 PCR的新应用使得能够选择性扩增含有突变的DNA片段。随后,在常规或纳米技术实时PCR平台上进行熔解曲线分析,以高通量和闭管方式检测包含突变的样品。我们将s-RT-MELT应用于细胞系和临床样品中p53和EGFR突变的筛选,并证明了其在癌症中快速,多重突变扫描以及生物学和医学中的遗传变异筛选的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号